AbbVie ABBV
CEO: Robert Michael · Pharmaceuticals · 50,000 employees
Compensation Breakdown
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.7M | — | $44.0M | $20.9M | $14.7M | $174K | $81.4M |
| 2024 | $1.7M | $722K | $39.1M | $13.1M | $14.0M | $91K | $68.7M |
| 2023 | $1.6M | — | $40.7M | $11.3M | $11.7M | $92K | $65.4M |
| 2022 | $1.6M | — | $25.2M | $14.0M | $7.0M | $26K | $47.8M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Frequently Asked Questions
Robert Michael, CEO of AbbVie (ABBV), earns $81.4M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
AbbVie has a Pay-for-Performance Score of D (37/100). The company's 3-year total shareholder return is -7.2%, and the say-on-pay shareholder vote passed with 97.6% approval.
The CEO-to-median-worker pay ratio at AbbVie is 1465:1. The median worker at AbbVie earns $56K per year, while CEO Robert Michael earns $81.4M in total compensation.
AbbVie employs approximately 50,000 people. The company operates in the Pharmaceuticals industry within the Healthcare sector, generating $54.3B in annual revenue.